It's not just AI — China's quickly gaining an edge over the U.S. in biotech
It's not just AI — China's quickly gaining an edge over the U.S. in biotech
www.cnbc.com
It's not just AI — China's quickly gaining an edge over the U.S. in biotech
4 comments
-
-
China’s biotech industry has evolved to the point that U.S. and European pharmaceutical giants in the last several months have spent billions to acquire China-developed drugs that could treat cancer if commercialized with regulatory approval. In March, British pharmaceutical giant AstraZeneca announced it will invest $2.5 billion in a research and development center in Beijing.
In case you thought research isn't subject to outsourcing.
-
This isn't outsourcing.
-
Nice to see what can be accomplished in a country that isn't openly hostile to science.
And long term economic planning, and therefore public investment in science.